AIDS Hiv medicine in handIn a move that could lead to the availability of cheap generic HIV/AIDS medicine manufactured without restrictions to benefit the developing world, the U.S. Patent & Trademark Office on January 23, 2008 revoked four key patents held by the pharmaceutical company Gilead Sciences on the drug tenofovir disoproxil fumarate (TDF). (Doctors Without Borders)

Leave a Reply